By Helgi Library - May 21, 2023
Zur Rose employed 2,283 employees in 2022, up 7.13% compared to the previous year. Historically, between 2010 and 2022,...
By Helgi Library - May 21, 2023
Zur Rose made a net profit of CHF -171 mil with revenues of CHF 1,608 mil in 2022, up by 24.2% and down by 6.77%, r...
By Helgi Library - May 22, 2023
Zur Rose stock traded at CHF 27.1 per share at the end 2022 translating into a market capitalization of USD 298 mil. Since the en...
| Profit Statement | 2028 | 2029 | 2030 | |
| Sales | CHF mil | 1,613 | 1,708 | 1,793 |
| Gross Profit | CHF mil | 337 | 362 | 385 |
| EBITDA | CHF mil | 85.2 | 104 | 123 |
| EBIT | CHF mil | 35.1 | 53.5 | 72.6 |
| Financing Cost | CHF mil | 15.0 | 15.0 | 15.0 |
| Pre-Tax Profit | CHF mil | 15.1 | 33.5 | 52.6 |
| Net Profit | CHF mil | 10.1 | 23.5 | 37.6 |
| Dividends | CHF mil | 0 | 0 | 0 |
| Balance Sheet | 2028 | 2029 | 2030 | |
| Total Assets | CHF mil | 1,144 | 1,182 | 1,220 |
| Non-Current Assets | CHF mil | 704 | 728 | 752 |
| Current Assets | CHF mil | 440 | 455 | 467 |
| Working Capital | CHF mil | 87.7 | 93.1 | 98.0 |
| Shareholders' Equity | CHF mil | 149 | 172 | 210 |
| Liabilities | CHF mil | 996 | 1,010 | 1,010 |
| Total Debt | CHF mil | 352 | 352 | 352 |
| Net Debt | CHF mil | 196 | 196 | 196 |
| Ratios | 2028 | 2029 | 2030 | |
| ROE | % | 7.04 | 14.7 | 19.7 |
| ROCE | % | 1.30 | 2.91 | 4.50 |
| Gross Margin | % | 20.9 | 21.2 | 21.5 |
| EBITDA Margin | % | 5.29 | 6.08 | 6.86 |
| EBIT Margin | % | 2.18 | 3.13 | 4.05 |
| Net Margin | % | 0.626 | 1.38 | 2.10 |
| Net Debt/EBITDA | 2.29 | 1.88 | 1.59 | |
| Net Debt/Equity | % | 132 | 114 | 93.3 |
| Cost of Financing | % | 4.26 | 4.26 | 4.26 |
| Valuation | 2028 | 2029 | 2030 | |
| Market Capitalisation | USD mil | 363 | 363 | 363 |
| Enterprise Value (EV) | USD mil | 577 | 577 | 577 |
| Number Of Shares | mil | 10.0 | 10.0 | 10.0 |
| Share Price | CHF | 33.0 | 33.0 | 33.0 |
| EV/EBITDA | 6.18 | 5.07 | 4.28 | |
| EV/Sales | 0.326 | 0.308 | 0.294 | |
| Price/Earnings (P/E) | 32.8 | 14.1 | 8.80 | |
| Price/Book Value (P/BV) | 2.23 | 1.92 | 1.58 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | ||||||||||||||||||||||
| Sales | CHF mil | 1,207 | 1,356 | 1,477 | 1,725 | 1,608 | ||||||||||||||||
| Gross Profit | CHF mil | 181 | 209 | 251 | 263 | 247 | ||||||||||||||||
| EBIT | CHF mil | -32.9 | -45.7 | -118 | -194 | -140 | ||||||||||||||||
| Net Profit | CHF mil | -39.0 | -52.4 | -136 | -226 | -171 | ||||||||||||||||
| ROE | % | ... | -10.6 | -12.3 | -29.0 | -44.4 | -41.0 | |||||||||||||||
| EBIT Margin | % | -2.72 | -3.37 | -7.96 | -11.2 | -8.72 | ||||||||||||||||
| Net Margin | % | -3.23 | -3.86 | -9.19 | -13.1 | -10.6 | ||||||||||||||||
| Employees | 1,314 | 1,710 | 1,960 | 2,131 | 2,283 | ... | ... | ... | ... | ... | ... | ... | ... | |||||||||
| balance sheet | ||||||||||||||||||||||
| Total Assets | CHF mil | 727 | 992 | 1,278 | 1,269 | 1,099 | ||||||||||||||||
| Non-Current Assets | CHF mil | 310 | 564 | 739 | 732 | 704 | ||||||||||||||||
| Current Assets | CHF mil | 417 | 428 | 539 | 537 | 396 | ||||||||||||||||
| Shareholders' Equity | CHF mil | 444 | 406 | 532 | 485 | 351 | ||||||||||||||||
| Liabilities | CHF mil | 283 | 586 | 747 | 784 | 749 | ||||||||||||||||
| Non-Current Liabilities | CHF mil | 164 | 374 | 590 | 572 | 507 | ||||||||||||||||
| Current Liabilities | CHF mil | 119 | 213 | 157 | 213 | 241 | ||||||||||||||||
| Net Debt/EBITDA | 5.90 | -16.8 | -3.44 | -2.04 | -5.12 | |||||||||||||||||
| Net Debt/Equity | % | -18.6 | 57.4 | 50.7 | 60.0 | 113 | ||||||||||||||||
| Cost of Financing | % | ... | 2.10 | 1.50 | 2.67 | 5.77 | 5.27 | |||||||||||||||
| cash flow | ||||||||||||||||||||||
| Total Cash From Operations | CHF mil | -33.2 | -82.6 | -67.5 | -131 | -97.3 | ||||||||||||||||
| Total Cash From Investing | CHF mil | -140 | -143 | -200 | -67.3 | -89.8 | ||||||||||||||||
| Total Cash From Financing | CHF mil | 297 | 200 | 363 | 180 | 39.1 | ||||||||||||||||
| Net Change In Cash | CHF mil | 123 | -26.0 | 95.9 | -22.9 | -152 | ||||||||||||||||
| valuation | ||||||||||||||||||||||
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 580 | 963 | 2,902 | 2,488 | 298 | |||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 496 | 1,203 | 3,206 | 2,807 | 734 | |||||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 6.35 | 8.66 | 9.08 | 9.65 | 10.0 | |||||||||
| Share Price | CHF | ... | ... | ... | ... | ... | ... | ... | 89.7 | 107 | 283 | 236 | 27.1 | |||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | -14.6 | -17.8 | -18.9 | -10.1 | -1.59 | ||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | -16.7 | -19.7 | -19.9 | -10.4 | -1.69 | ||||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | -34.7 | -84.9 | -37.8 | -17.7 | -8.63 | ||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.28 | 2.29 | 4.83 | 4.68 | 0.776 | ||||||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 |
| income statement | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | ||||||||||||||||||||||
| Sales | CHF mil | 1,207 | 1,356 | 1,477 | 1,725 | 1,608 | ||||||||||||||||
| Cost of Goods & Services | CHF mil | 1,026 | 1,147 | 1,226 | 1,462 | 1,361 | ||||||||||||||||
| Gross Profit | CHF mil | 181 | 209 | 251 | 263 | 247 | ||||||||||||||||
| Selling, General & Admin | CHF mil | 66.2 | 88.1 | 111 | ... | 118 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Research & Development | CHF mil | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Other Operating Expense | CHF mil | 977 | 1,120 | 1,215 | 1,620 | 1,605 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Staff Cost | CHF mil | 93.7 | 117 | 143 | 148 | 156 | ||||||||||||||||
| Other Operating Cost (Income) | CHF mil | 3.07 | 42.0 | 14.8 | 6.75 | 23.1 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| EBITDA | CHF mil | -14.0 | -13.8 | -78.4 | -143 | -77.7 | ||||||||||||||||
| Depreciation | CHF mil | 4.92 | 5.10 | 6.65 | 7.92 | 10.3 | ||||||||||||||||
| EBIT | CHF mil | -32.9 | -45.7 | -118 | -194 | -140 | ||||||||||||||||
| Net Financing Cost | CHF mil | 1.46 | 4.35 | 12.6 | 32.9 | 29.6 | ||||||||||||||||
| Financing Cost | CHF mil | 1.70 | 4.40 | 13.5 | 32.9 | 29.6 | ||||||||||||||||
| Financing Income | CHF mil | 0.237 | 0.051 | 0.929 | 0 | 0 | ||||||||||||||||
| FX (Gain) Loss | CHF mil | 3.89 | -1.34 | -2.15 | 0 | 0 | ||||||||||||||||
| (Income) / Loss from Affiliates | CHF mil | -0.173 | -0.031 | 3.30 | 8.55 | 1.49 | ||||||||||||||||
| Extraordinary Cost | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| Pre-Tax Profit | CHF mil | -38.5 | -50.1 | -133 | -227 | -170 | ||||||||||||||||
| Tax | CHF mil | 0.553 | 2.27 | 2.44 | -0.949 | 1.25 | ||||||||||||||||
| Minorities | CHF mil | -0.129 | -0.018 | 0.051 | 0 | 0 | ||||||||||||||||
| Net Profit | CHF mil | -39.0 | -52.4 | -136 | -226 | -171 | ||||||||||||||||
| Net Profit Avail. to Common | CHF mil | -39.0 | -52.4 | -136 | -226 | -171 | ||||||||||||||||
| Dividends | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| growth rates | ||||||||||||||||||||||
| Total Revenue Growth | % | ... | 22.8 | 12.3 | 8.96 | 16.8 | -6.77 | |||||||||||||||
| Operating Cost Growth | % | ... | 20.6 | 16.1 | 11.5 | 19.7 | -8.06 | ... | ... | ... | ... | ... | ... | ... | ... | |||||||
| Staff Cost Growth | % | ... | 19.6 | 25.4 | 21.6 | 3.81 | 4.88 | |||||||||||||||
| EBITDA Growth | % | ... | -33.9 | -1.16 | 466 | 82.0 | -45.6 | |||||||||||||||
| EBIT Growth | % | ... | -14.2 | 39.1 | 157 | 64.7 | -27.6 | |||||||||||||||
| Pre-Tax Profit Growth | % | ... | 5.59 | 30.0 | 166 | 70.2 | -25.1 | |||||||||||||||
| Net Profit Growth | % | ... | 7.54 | 34.4 | 159 | 66.4 | -24.2 | |||||||||||||||
| ratios | ||||||||||||||||||||||
| ROE | % | ... | -10.6 | -12.3 | -29.0 | -44.4 | -41.0 | |||||||||||||||
| ROA | % | ... | -6.56 | -6.09 | -12.0 | -17.7 | -14.4 | |||||||||||||||
| ROCE | % | ... | -12.1 | -9.90 | -17.8 | -26.9 | -21.0 | |||||||||||||||
| Gross Margin | % | 15.0 | 15.4 | 17.0 | 15.2 | 15.3 | ||||||||||||||||
| EBITDA Margin | % | -1.16 | -1.02 | -5.31 | -8.27 | -4.83 | ||||||||||||||||
| EBIT Margin | % | -2.72 | -3.37 | -7.96 | -11.2 | -8.72 | ||||||||||||||||
| Net Margin | % | -3.23 | -3.86 | -9.19 | -13.1 | -10.6 | ||||||||||||||||
| Payout Ratio | % | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| Cost of Financing | % | ... | 2.10 | 1.50 | 2.67 | 5.77 | 5.27 | |||||||||||||||
| Net Debt/EBITDA | 5.90 | -16.8 | -3.44 | -2.04 | -5.12 |
| balance sheet | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| balance sheet | ||||||||||||||||||||||
| Cash & Cash Equivalents | CHF mil | 231 | 205 | 301 | 278 | 156 | ||||||||||||||||
| Receivables | CHF mil | 92.3 | 127 | 115 | 132 | 129 | ||||||||||||||||
| Unbilled Revenues | CHF mil | ... | ... | ... | ... | ... | ... | ... | 3.93 | 0.415 | 0.419 | 0.469 | 0.601 | ... | ... | ... | ... | ... | ... | ... | ... | |
| Inventories | CHF mil | 69.4 | 70.6 | 92.9 | 92.5 | 83.2 | ||||||||||||||||
| Other ST Assets | CHF mil | 20.3 | 25.4 | 30.0 | 34.0 | 26.4 | ||||||||||||||||
| Current Assets | CHF mil | 417 | 428 | 539 | 537 | 396 | ||||||||||||||||
| Property, Plant & Equipment | CHF mil | 34.3 | 77.1 | 96.6 | 98.7 | 96.8 | ||||||||||||||||
| LT Investments & Receivables | CHF mil | 1.08 | 6.16 | 27.9 | 29.4 | 28.4 | ||||||||||||||||
| Intangible Assets | CHF mil | 265 | 465 | 605 | 595 | 572 | ||||||||||||||||
| Goodwill | CHF mil | 172 | 335 | 435 | 418 | 401 | ||||||||||||||||
| Non-Current Assets | CHF mil | 310 | 564 | 739 | 732 | 704 | ||||||||||||||||
| Total Assets | CHF mil | 727 | 992 | 1,278 | 1,269 | 1,099 | ||||||||||||||||
| Trade Payables | CHF mil | 83.1 | 92.1 | 93.3 | 132 | 113 | ||||||||||||||||
| Short-Term Debt | CHF mil | 3.52 | 87.4 | 6.80 | 16.4 | 61.2 | ||||||||||||||||
| Other ST Liabilities | CHF mil | 9.53 | 6.92 | 14.7 | 63.9 | 18.6 | ||||||||||||||||
| Current Liabilities | CHF mil | 119 | 213 | 157 | 213 | 241 | ||||||||||||||||
| Long-Term Debt | CHF mil | 145 | 350 | 564 | 553 | 493 | ||||||||||||||||
| Other LT Liabilities | CHF mil | 19.2 | 23.4 | 26.3 | 19.0 | 14.2 | ||||||||||||||||
| Non-Current Liabilities | CHF mil | 164 | 374 | 590 | 572 | 507 | ||||||||||||||||
| Liabilities | CHF mil | 283 | 586 | 747 | 784 | 749 | ||||||||||||||||
| Preferred Equity and Hybrid Capital | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| Share Capital | CHF mil | 48.1 | 262 | 316 | 336 | 405 | ||||||||||||||||
| Treasury Stock | CHF mil | 5.45 | 5.22 | 31.9 | 31.3 | 60.7 | ||||||||||||||||
| Equity Before Minority Interest | CHF mil | 444 | 406 | 532 | 485 | 351 | ||||||||||||||||
| Minority Interest | CHF mil | 0.030 | -0.110 | 0 | 0 | 0 | ||||||||||||||||
| Equity | CHF mil | 444 | 406 | 532 | 485 | 351 | ||||||||||||||||
| growth rates | ||||||||||||||||||||||
| Total Asset Growth | % | ... | 57.3 | 36.5 | 28.9 | -0.725 | -13.4 | |||||||||||||||
| Shareholders' Equity Growth | % | ... | 50.8 | -8.58 | 31.1 | -8.80 | -27.7 | |||||||||||||||
| Net Debt Growth | % | ... | -12.8 | -382 | 15.9 | 7.91 | 36.8 | |||||||||||||||
| Total Debt Growth | % | ... | 1,019 | 195 | 30.4 | -0.254 | -2.60 | |||||||||||||||
| ratios | ||||||||||||||||||||||
| Total Debt | CHF mil | 148 | 438 | 571 | 569 | 554 | ||||||||||||||||
| Net Debt | CHF mil | -82.6 | 233 | 270 | 291 | 398 | ||||||||||||||||
| Working Capital | CHF mil | 78.6 | 105 | 115 | 92.3 | 99.8 | ||||||||||||||||
| Capital Employed | CHF mil | 388 | 669 | 854 | 824 | 803 | ||||||||||||||||
| Net Debt/Equity | % | -18.6 | 57.4 | 50.7 | 60.0 | 113 | ||||||||||||||||
| Current Ratio | 3.50 | 2.01 | 3.44 | 2.53 | 1.64 | |||||||||||||||||
| Quick Ratio | 2.72 | 1.56 | 2.65 | 1.93 | 1.18 |
| cash flow | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| cash flow | ||||||||||||||||||||||
| Net Profit | CHF mil | -39.0 | -52.4 | -136 | -226 | -171 | ||||||||||||||||
| Depreciation | CHF mil | 4.92 | 5.10 | 6.65 | 7.92 | 10.3 | ||||||||||||||||
| Non-Cash Items | CHF mil | 5.26 | -34.9 | 26.6 | 23.8 | 6.15 | ||||||||||||||||
| Change in Working Capital | CHF mil | -18.4 | -27.2 | 2.32 | 20.2 | 5.05 | ||||||||||||||||
| Total Cash From Operations | CHF mil | -33.2 | -82.6 | -67.5 | -131 | -97.3 | ||||||||||||||||
| Capital Expenditures | CHF mil | -31.5 | -41.5 | -59.8 | -63.5 | -58.7 | ||||||||||||||||
| Net Change in LT Investment | CHF mil | -0.450 | -3.21 | -24.0 | -2.50 | -4.14 | ||||||||||||||||
| Net Cash From Acquisitions | CHF mil | -109 | -103 | -116 | -2.59 | -0.596 | ||||||||||||||||
| Other Investing Activities | CHF mil | 0.244 | 4.62 | 0.025 | 1.23 | -26.3 | ||||||||||||||||
| Total Cash From Investing | CHF mil | -140 | -143 | -200 | -67.3 | -89.8 | ||||||||||||||||
| Dividends Paid | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| Issuance Of Shares | CHF mil | 185 | 0.495 | 206 | 187 | 38.6 | ||||||||||||||||
| Issuance Of Debt | CHF mil | 112 | 200 | 158 | -7.58 | 0.506 | ||||||||||||||||
| Other Financing Activities | CHF mil | 0 | -0.314 | -0.743 | 0 | 0 | ||||||||||||||||
| Total Cash From Financing | CHF mil | 297 | 200 | 363 | 180 | 39.1 | ||||||||||||||||
| Effect of FX Rates | CHF mil | -0.624 | -0.450 | 0.053 | -4.63 | -3.75 | ||||||||||||||||
| Net Change In Cash | CHF mil | 123 | -26.0 | 95.9 | -22.9 | -152 | ||||||||||||||||
| ratios | ||||||||||||||||||||||
| Days Sales Outstanding | days | 27.9 | 34.1 | 28.4 | 27.9 | 29.4 | ||||||||||||||||
| Days Sales Of Inventory | days | 24.7 | 22.5 | 27.7 | 23.1 | 22.3 | ||||||||||||||||
| Days Payable Outstanding | days | 29.6 | 29.3 | 27.8 | 33.0 | 30.2 | ||||||||||||||||
| Cash Conversion Cycle | days | 23.0 | 27.3 | 28.3 | 18.0 | 21.4 | ||||||||||||||||
| Cash Earnings | CHF mil | -34.1 | -47.3 | -129 | -218 | -161 | ||||||||||||||||
| Free Cash Flow | CHF mil | -174 | -226 | -267 | -198 | -187 | ||||||||||||||||
| Capital Expenditures (As % of Sales) | % | 2.61 | 3.06 | 4.05 | 3.68 | 3.65 |
| other ratios | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Employees | 1,314 | 1,710 | 1,960 | 2,131 | 2,283 | ... | ... | ... | ... | ... | ... | ... | ... | |||||||||
| Cost Per Employee | USD per month | 6,062 | 5,863 | 6,571 | 6,468 | 6,223 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Cost Per Employee (Local Currency) | CHF per month | 5,942 | 5,726 | 6,076 | 5,801 | 5,679 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Women (As % of Workforce) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 54.8 | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| Women (As % of Management) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 22.2 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| Material & Energy (As % of Sales) | % | 85.0 | 84.6 | 83.0 | 84.8 | 84.7 | ||||||||||||||||
| Services (As % of Sales) | % | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
| Marketing Cost (As % of Sales) | % | ... | ... | ... | ... | 3.42 | 3.93 | 4.10 | 6.89 | 3.63 | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Operating Cost (As % of Sales) | % | 103 | 106 | 109 | 112 | 110 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Research & Development (As % of Sales) | % | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Staff Cost (As % of Sales) | % | 7.76 | 8.67 | 9.68 | 8.60 | 9.67 | ||||||||||||||||
| Effective Tax Rate | % | -1.43 | -4.52 | -1.83 | 0.419 | -0.734 | ||||||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 5.80 | 8.16 | 12.1 | 14.4 | 10.3 | |||||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 11.7 | 13.5 | 11.9 | ||||||||
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | 6.00 | 7.08 | 10.5 | 12.4 | 10.4 |
| valuation | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 580 | 963 | 2,902 | 2,488 | 298 | |||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 496 | 1,203 | 3,206 | 2,807 | 734 | |||||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 6.35 | 8.66 | 9.08 | 9.65 | 10.0 | |||||||||
| Share Price | CHF | ... | ... | ... | ... | ... | ... | ... | 89.7 | 107 | 283 | 236 | 27.1 | |||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | -34.7 | -84.9 | -37.8 | -17.7 | -8.63 | ||||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | -14.6 | -17.8 | -18.9 | -10.1 | -1.59 | ||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | -16.7 | -19.7 | -19.9 | -10.4 | -1.69 | ||||||||||
| P/FCF | ... | ... | ... | ... | ... | ... | ... | -3.28 | -4.12 | -9.61 | -11.5 | -1.46 | ... | ... | ... | ... | ... | |||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.28 | 2.29 | 4.83 | 4.68 | 0.776 | ||||||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||
| Free Cash Flow Yield | % | ... | ... | ... | ... | ... | ... | ... | -30.5 | -24.0 | -9.96 | -8.87 | -68.7 | |||||||||
| Earnings Per Share (EPS) | CHF | ... | ... | ... | ... | ... | ... | ... | -6.14 | -6.04 | -15.0 | -23.4 | -17.0 | |||||||||
| Cash Earnings Per Share | CHF | ... | ... | ... | ... | ... | ... | ... | -5.36 | -5.45 | -14.2 | -22.6 | -16.0 | |||||||||
| Free Cash Flow Per Share | CHF | ... | ... | ... | ... | ... | ... | ... | -27.3 | -26.1 | -29.5 | -20.5 | -18.6 | |||||||||
| Book Value Per Share | CHF | ... | ... | ... | ... | ... | ... | ... | 69.9 | 46.8 | 58.6 | 50.3 | 34.9 | |||||||||
| Dividend Per Share | CHF | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||
| EV/Sales | ... | ... | ... | ... | ... | ... | ... | 0.403 | 0.867 | 2.01 | 1.46 | 0.417 | ||||||||||
| EV/EBIT | ... | ... | ... | ... | ... | ... | ... | -14.8 | -25.7 | -25.2 | -13.0 | -4.78 | ||||||||||
| EV/Free Cash Flow | ... | ... | ... | ... | ... | ... | ... | -2.80 | -5.21 | -11.1 | -12.7 | -3.58 | ... | ... | ... | ... | ... | |||||
| EV/Capital Employed | ... | ... | ... | ... | ... | ... | ... | 1.25 | 1.74 | 3.32 | 3.11 | 0.834 | ||||||||||
| Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | -6.66 | -1.56 | 147 | 56.5 | -27.2 | ||||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | -8.75 | 1.68 | 161 | 58.8 | -29.1 | ||||||||
| Book Value Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 30.9 | -33.0 | 25.2 | -14.2 | -30.5 | ||||||||
| Market Value per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | 96.6 | 136 | 276 | 201 | 28.7 | ||||||||
| Sales per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | 205 | 196 | 152 | 155 | 169 | ||||||||
| EBITDA per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | -2.38 | -2.00 | -8.07 | -12.8 | -8.18 | ||||||||
| Net Profit per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | -6.63 | -7.58 | -14.0 | -20.3 | -18.0 |
| clients & arpu | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | 6.00 | 7.08 | 10.5 | 12.4 | 10.4 | ||||||||
| Basket Size (USD) | USD | ... | ... | ... | ... | ... | ... | ... | ... | 71.5 | 64.6 | 63.5 | 67.1 | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| Order Frequency | ... | ... | ... | ... | ... | ... | ... | ... | 2.60 | 2.40 | 2.20 | 2.10 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Repeat Order Rate | % | ... | ... | ... | ... | ... | ... | 81.0 | 79.0 | 76.0 | 74.0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Site Visits | mil | ... | ... | ... | ... | ... | ... | ... | ... | 146 | 216 | 244 | 265 | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| Marketing Expenses | CHF mil | ... | ... | ... | ... | ... | ... | 41.3 | 53.2 | 60.6 | 119 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Marketing Expenses (As % of Sales) | % | ... | ... | ... | ... | ... | ... | 3.42 | 3.92 | 4.10 | 6.89 | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
By Helgi Library - May 22, 2023
Zur Rose made a net profit of CHF -171 mil with revenues of CHF 1,608 mil in 2022, up by 24.2% and down by 6.77%, respectively, compared to the previous year. This translates into a net margin of -10.6%. On the operating level, EBITDA reached CHF -77.7 mil,...
By Helgi Library - May 21, 2023
Zur Rose made a net profit of CHF -171 mil with revenues of CHF 1,608 mil in 2022, up by 24.2% and down by 6.77%, respectively, compared to the previous year. This translates into a net margin of -10.6%. Historically, between 2010 and 2022, the firm...
By Helgi Library - May 21, 2023
Zur Rose invested a total of CHF 58.7 mil in 2022, down 7.5% compared to the previous year. Historically, between 2010 - 2022, the company's investments stood at a high of CHF 63.5 mil in 2021 and a low of CHF 3.07 mil in 2011. As a p...
By Helgi Library - May 21, 2023
Zur Rose made a net profit of CHF -171 mil in 2022, up 24.2% compared to the previous year. Historically, between 2010 and 2022, the company's net profit reached a high of CHF 8.67 mil in 2011 and a low of CHF -226 mil in 2021. The result implies a return...
By Helgi Library - May 22, 2023
Zur Rose stock traded at CHF 27.1 per share at the end 2022 implying a market capitalization of USD 298 mil. Since the end of 2017, stock has appreciated by -78.1% implying an annual average growth of -26.2% In absolute terms, the value of the company fe...
By Helgi Library - May 22, 2023
Zur Rose stock traded at CHF 27.1 per share at the end 2022 translating into a market capitalization of USD 298 mil. Since the end of 2017, the stock has depreciated by 78.1% representing an annual average growth of -26.2%. At the end of 2022, the firm t...
By Helgi Library - May 21, 2023
Zur Rose's net debt stood at CHF 398 mil and accounted for 113% of equity at the end of 2022. The ratio is up 53.4 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 113% in 2022 and a low of -32.2...
By Helgi Library - August 3, 2020
Zur Rose made a net profit of CHF -17.6 mil with revenues of CHF 344 mil in 4Q2019, down by 64.3% and up by 13.7%, respectively, compared to the previous year. This translates into a net margin of -5.13%. On the operating level, EBITDA reached CHF -5.69 m...
By Helgi Library - August 3, 2020
Zur Rose's operating cash flow stood at CHF -33.6 mil in 4Q2019, down 239% when compared to the previous year. Historically, between 1Q2009 - 4Q2019, the firm’s operating cash flow reached a high of CHF 5.23 mil in 3Q2012 and a low of CHF -33.6 mil ...
By Helgi Library - October 12, 2020
Zur Rose's total assets reached CHF 992 mil at the end of 4Q2019, up 36.5% compared to the previous year. Current assets amounted to CHF 428 mil, or 43.2% of total assets while cash stood at CHF 205 mil at the end of 4Q2019. ...
The Swiss Zur Rose Group is Europe’s largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. The Company also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany’s best-known pharmacy brand DocMorris. Zur Rose employs more than 1,800 people at sites in Switzerland, Germany, the Netherlands, Spain and France. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
DocMorris has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2030, or of sales. That’s compared to % average margin seen in last five years.
The company netted in 2030 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.
DocMorris’s net debt amounted to at the end of 2030, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.
DocMorris stock traded at per share at the end of 2030 resulting in a market capitalization of . Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2030.
Helgi Library 
